Atlas Trials

A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer

Clinical trial NCT07693751 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07693751
Sponsor
SOTIO Biotech a.s.
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer (Locally Advanced or Metastatic)
Start date
2026-08-29
Primary completion
2027-11-29
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.